FDA Discussed 2021 Drug Warnings & Approvals at ACR Annual Meeting
Considerations for Prescribing Avacopan for ANCA-Associated Vasculitis
FDA Approves Avacopan for the Treatment of ANCA-Associated Vasculitis
FDA’s Arthritis Advisory Committee Narrowly Endorses Avacopan Approval
Study: Can Avacopan Replace Steroids in ANCA-Associated Vasculitis?
Researchers Seek ANCA-Associated Vasculitis Subtype Markers
ANCA-Associated Vasculitis Trial Results May Change Standard of Care
